HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM was delisted on the 14th of June, 2023.
20 hedge funds and large institutions have $16M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
5% less funds holding
Funds holding: 21 → 20 (-1)
44% less capital invested
Capital invested by funds: $28.6M → $16M (-$12.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Securian Asset Management
St Paul,
Minnesota
|
+$76.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$32.4K |
| 3 |
US Bancorp
Minneapolis,
Minnesota
|
+$8.85K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.88K |
| 5 |
SIM
Sonora Investment Management
Tucson,
Arizona
|
+$4.92K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$398K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$185K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$134K |
| 4 |
Citigroup
New York
|
-$1K |
HTGM Hedge Fund Activity: Q4 2015 in Review
20 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) for Q4 2015, worth a combined $16M — down 44% from $28.6M a quarter earlier.
Fund positioning in HTGM was balanced in Q4 2015: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Securian Asset Management, opening a new position worth an estimated $76.7K. The largest seller was UBS O'Connor, exiting entirely with an estimated $398K sold.
- 20 institutional investors held HTG Molecular Diagnostics, Inc. Common Stock (HTGM) as of Q4 2015, down from 21 in Q3 2015.
- Funds reported $16M of HTG Molecular Diagnostics, Inc. Common Stock stock for Q4 2015, down 44% quarter-over-quarter.
- 3 funds opened new HTG Molecular Diagnostics, Inc. Common Stock positions in Q4 2015 and 3 closed out, a net change of 0 holders.
- The largest HTG Molecular Diagnostics, Inc. Common Stock buyer in Q4 2015 was Securian Asset Management, an estimated $76.7K added.
- The largest HTG Molecular Diagnostics, Inc. Common Stock seller in Q4 2015 was UBS O'Connor, an estimated $398K sold.
Based on aggregated 13F filings for Q4 2015.